Pure Global AI
Manufacturer profile

Schazoo SPL Consumer Healthcare

Pakistan20 registrations20 distinct products
VerifiedDRAP · official registry
20
Total Registrations
20
Distinct Products
6/28/2022
Latest Registration
6/4/2021
Earliest
Regulatory footprint
Search Schazoo SPL Consumer Healthcare across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk class distribution
Risk D17
Risk B2
Risk C1
Registrations (20)
Click a registration to view details
Ellanse M (AQTIS Medical Dermal filler) [1ml]
6/28/2022
Registration
MDIR-0003512
Risk Class
D
Expires
6/27/2027
MagPure Viral Nucleic Acid Isolation kit. [48 tests/ kit 96 tests/ kit 200 tests/ kit 500 tests/ kit ]
6/28/2022
Registration
MDIR-0003525
Risk Class
B
Expires
6/27/2027
Perfectha Deep Lidocaine [PDDL (1x1ml) Accessories (Plunger rod and backstop)]
6/28/2022
Registration
MDIR-0003524
Risk Class
D
Expires
6/27/2027
Perfectha Derm Lidocaine [PDL (1x1ml) Accessories (Plunger rod and backstop)]
6/28/2022
Registration
MDIR-0003523
Risk Class
D
Expires
6/27/2027
Perfectha Subskin Lidocaine [PDSSL (3x1ml) Accessories (3 x Plungers rods and 3 x backstops)]
6/28/2022
Registration
MDIR-0003522
Risk Class
D
Expires
6/27/2027
Perfectha Finelines Lidocaine [PDFLL (1x1ml) Accessories (2 x 30G x13mm needles Plunger rod and backstop)]
6/28/2022
Registration
MDIR-0003521
Risk Class
D
Expires
6/27/2027
MAILI Define (Injectable HA gel) Cross-Linked hyaluronic acid: 18 mg/ml) [MAI-110]
6/28/2022
Registration
MDIR-0003520
Risk Class
D
Expires
6/27/2027
MAILI Extreme (Injectable HA gel) Cross-Linked hyaluronic acid: 24 mg/ml) [MAI-310]
6/28/2022
Registration
MDIR-0003519
Risk Class
D
Expires
6/27/2027
MAILI Volume (Injectable HA gel) Cross-Linked hyaluronic acid: 21 mg/ml) [MAI-210]
6/28/2022
Registration
MDIR-0003518
Risk Class
D
Expires
6/27/2027
MAILI Precise (Injectable HA gel) Cross-Linked hyaluronic acid: 15 mg/ml) [MAI-010]
6/28/2022
Registration
MDIR-0003517
Risk Class
D
Expires
6/27/2027
Lanluma V (Injectable Poly-L-Lactic acid powder 210mg/15ml)
6/28/2022
Registration
MDIR-0003516
Risk Class
D
Expires
6/27/2027
Lanluma X (Injectable Poly-L-Lactic acid powder 630mg/40ml)
6/28/2022
Registration
MDIR-0003515
Risk Class
D
Expires
6/27/2027
Silhouette SOFT (Sterile resorbable Silhouette Soft Suture with needles)
6/28/2022
Registration
MDIR-0003514
Risk Class
D
Expires
6/27/2027
Ellanse S (AQTIS Medical Dermal filler) [1ml]
6/28/2022
Registration
MDIR-0003513
Risk Class
D
Expires
6/27/2027
HAIOU Auto-Disable Syringe (for fixed dose Immunization) [0.05 ml, 0.3ml, 0.5 ml]
1/6/2022
Registration
MDIR-0003122
Risk Class
B
Expires
1/5/2027
Hyamira Forte (Reticulated Hyaluronic Acid: 25mg/ml)
8/11/2021
Registration
MDIR-0002744
Risk Class
D
Expires
8/10/2026
Hyamira Basic (Reticulated Hyaluronic Acid: 20mg/ml.
8/11/2021
Registration
MDIR-0002743
Risk Class
D
Expires
8/10/2026
Hyamira Soft (Reticulated Hyaluronic Acid: 15mg/ml)
8/11/2021
Registration
MDIR-0002745
Risk Class
D
Expires
8/10/2026
Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m
8/11/2021
Registration
MDIR-0002746
Risk Class
D
Expires
8/10/2026
Wondfo 2019-nCoV Real Time-RT PCR Assay kit [W275P002]
6/4/2021
Registration
MDIR-0002580
Risk Class
C
Expires
6/3/2026
About this profile

Access the DRAP portfolio for Schazoo SPL Consumer Healthcare via Pure Global AI. This manufacturer holds 20 registrations across 20 distinct products, with registrations ranging from 6/4/2021 to 6/28/2022 and spanning 3 risk classes.

This mirrors the Brazil holder experience with a concise snapshot and direct links to each DRAP registration.